Rambus Inc. Profile Avatar - Palmy Investing

Rambus Inc.

Rambus Inc. provides semiconductor products in the United States, Taiwan, South Korea, Japan, Europe, Canada, Singapore, China, and internationally. The company offers DDR memory interface chips, including DDR5, DDR4 and DDR3 memory interface chips to mo…
Semiconductors
US, San Jose [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 10.82 158.94 143.42
Graham Fair Price -27.00 7.93 10.86
PEG -58.13 -1.15 -0.73
Price/Book -4.20 6.78 7.08
Price/Cash Flow 37.00 186.27 135.96
Prices/Earnings 62.85 51.12 31.39
Price/Sales -5.11 57.07 60.14
Price/FCF 37.00 186.27 135.96
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -11.55 0.73 0.83
Operating Margin -11.84 0.26 0.30
ROA -41.61 0.03 0.05
ROE 0.06 0.03 -41.17
ROIC 0.03 0.03 -8.55
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ < 0.005 0.01 -79.42
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.65 -0.15 77.10
EPS QOQ -0.43 -0.44 -2.98
FCF QOQ 0.24 -0.33 38.71
Revenue QOQ 0.16 -0.04 -77.84
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 154.47 135.67 -12.18
Days Sales Outstanding (DSO) 98.52 95.77 -2.80
Inventory Turnover 0.58 0.66 13.86
Debt/Capitalization 0.03 0.03 4.26
Quick Ratio 6.28 6.25 -0.43
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 9.64 9.17 -4.82
Cash 3.95 3.62 -8.50
Capex < 0.005 -0.03 -281.33
Free Cash Flow 0.50 0.33 -33.45
Revenue 1.13 1.09 -3.91
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 7.08 6.98 -1.38
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -1.26 -1.96 -55.55
Naive Interpretation Member
06 - Financial Health · Bad
End of RMBS's Analysis
CIK: 917273 CUSIP: 750917106 ISIN: US7509171069 LEI: - UEI: -
Secondary Listings